ConductScience.org, home

Trial · NCT07902830

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants With Treatment-emergent Adverse Events (TEAEs)Up to Week 56
PrimaryPercent Change in Average Daily G-CSF DosageWeek 12 through Week 28 or 32
PrimaryPercentage of Participants Achieving G-CSF CessationWeek 28 or 32
PrimaryPercentage of Participants Achieving G-CSF Dosage Reduction ≥75%Week 28 or 32
SecondaryPercentage of Participants Achieving G-CSF Dosage Reduction by ≥ 25%/≥ 50%Week 12 through Week 28 or 32
SecondaryTime to G-CSF CessationWeek 4 through Week 28 or 32
SecondaryTime to G-CSF Dosage Reduction of ≥25% or ≥50% or ≥75Week 4 through Week 28 or 32
SecondaryChange From Week 12 in Average Daily G-CSF Dosage at Week 28 or 32Week 12, Week 28 or 32
SecondaryChange From Week 12 in Average Daily G-CSF Frequency at Week 28 or 32Week 12, Week 28 or 32
Secondary
Change From Week 4 in Bone Pain up to Week 56, Assessed Using Patient-Reported Outcomes Measurement Information System Short Form (PROMIS SF) Pain Intensity Scale Score (Participants Aged 12 to <18 Years)
Week 4, up to Week 56
SecondaryChange From Week 4 in Bone Pain up to Week 56, Assessed Using Functional Assessment of Chronic Illness Therapy (FACIT) Bone Pain Scale Score (Participants Aged ≥18 Years)Week 4, up to Week 56
SecondaryChange From Week 4 in Fatigue up to Week 56, Assessed Using PROMIS SF Fatigue Scale Score (Participants Aged 12 to <18 Years)Week 4, up to Week 56
SecondaryChange From Week 4 in Fatigue up to Week 56, Assessed Using FACIT-Fatigue Scale Score (Participants Aged ≥18 years)Week 4, up to Week 56

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07902830/registered